1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) June 21, 1999
------------------
Chad Therapeutics, Inc.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
California
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-11363 95-3792700
- --------------------------------------------------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
21622 Plummer Street, Chatsworth, CA 91311
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(818) 882-0883
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
2
Item 6. Resignations of Registrant's Directors.
On June 21, 1999, the Board of Directors accepted the resignation of
Francis R. Fleming from the Board of Directors of Chad Therapeutics, Inc.
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CHAD THERAPEUTICS, INC.
Date July 9, 1999 By /S/Earl L. Yager
---------------- ---------------------------------------
Earl L. Yager, Executive Vice President
and Chief Financial Officer
3